{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:45:10Z","timestamp":1791233110854,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Clinical Special Science Fund of Science and Technology of Jiangsu Province","award":["BL2013006"],"award-info":[{"award-number":["BL2013006"]}]},{"name":"Six-Talent Peak Fund of Jiangsu Province","award":["WSW-063"],"award-info":[{"award-number":["WSW-063"]}]},{"name":"333 High-level Personnel Training Project Fund of Jiangsu Province","award":["BRA2015051"],"award-info":[{"award-number":["BRA2015051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12906-017-2029-0","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T07:22:23Z","timestamp":1512544943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Coptis Chinensis affects the function of glioma cells through the down-regulation of phosphorylation of STAT3 by reducing HDAC3"],"prefix":"10.1186","volume":"17","author":[{"given":"Jiangan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhemin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-1323","authenticated-orcid":false,"given":"Xiaojie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"issue":"1017","key":"2029_CR1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1259\/bjr\/83796755","volume":"85","author":"K ROCK","year":"2012","unstructured":"ROCK K, MCDRALE O, FORDE P, et al. A clinical review of treatment outcomes in glioblastoma multiforme-the validation in a non-trial population of the results of a randomised phase III clinical trial: has a more radical approach improved survival? [J]. Br J Radiol. 2012;85(1017):729\u201333.","journal-title":"Br J Radiol"},{"issue":"4","key":"2029_CR2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0360-3016(97)00915-2","volume":"40","author":"K Hopkins","year":"1998","unstructured":"Hopkins K, Chandler C, Eatough J, et al. Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into mormal brain parenchyma: a model to estimate absorbed radiation dose [J]. Int J Radiat Oncol Biol Phys. 1998;40(4):835\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2029_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1472-6882-13-132","volume":"13","author":"Q Xu","year":"2013","unstructured":"Xu Q, Bauer R, Hendry BM, et al. The quest for modernization of traditional Chinese medicine [J]. BMC Complement Altern Med. 2013;13:132. \nhttps:\/\/doi.org\/10.1186\/ 1472-6882-13-132\n\n.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"2029_CR4","first-page":"60","volume":"27","author":"J Da-wei","year":"2007","unstructured":"Da-wei J, Wei P-k. TCM herbs for clearing heat and eliminating toxins to prevent and treat malignant tumors: medical mechanism and application [J]. Jilin J Tradit Chin Med. 2007;27(1):60\u20132.","journal-title":"Jilin J Tradit Chin Med"},{"issue":"37","key":"2029_CR5","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","volume":"26","author":"XJ Yang","year":"2007","unstructured":"Yang XJ, Seto E. HATs and HDACs: from structure, function and regulation to movel strategies for therapy and prevention [J]. Oncogene. 2007;26(37):5310\u20138.","journal-title":"Oncogene"},{"issue":"3","key":"2029_CR6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cellsig.2006.09.003","volume":"19","author":"HS Kim","year":"2007","unstructured":"Kim HS, Lee MS. STAT1 as a key modulator of cell death [J]. Cell Signal. 2007;19(3):454\u201365.","journal-title":"Cell Signal"},{"issue":"1","key":"2029_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer [J]. Cytokine Growth Factor Rev. 2010;21(1):11\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"2029_CR8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1101\/gad.1643908","volume":"22","author":"L Hennighausen","year":"2008","unstructured":"Hennighausen L, Robinson GW. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B [J]. Genes Dev. 2008;22(6):711\u201321.","journal-title":"Genes Dev"},{"issue":"2","key":"2029_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O\u2019Shea","year":"2013","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer [J]. N Engl J Med. 2013;368(2):161\u201370.","journal-title":"N Engl J Med"},{"issue":"8","key":"2029_CR10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd4088","volume":"12","author":"G Miklossy","year":"2013","unstructured":"Miklossy G, Hilliard TS, Turkson J. Therapeutic modulatros of STAT signaling for human diseases [J]. Nat Rev Drug Discov. 2013;12(8):611\u201329.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2029_CR11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","volume":"96","author":"M Dokmanovic","year":"2005","unstructured":"Dokmanovic M, Marks PA. Prospects: histone deacetylase inhibitors [J]. J Cell Biochem. 2005;96(2):293\u2013304.","journal-title":"J Cell Biochem"},{"issue":"5","key":"2029_CR12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1142\/S0192415X16500506","volume":"44","author":"T Friedemann","year":"2016","unstructured":"Friedemann T, Ying Y, Wang W, Kramer ER, Schumacher U, Fei J, Schroder S. Neuroprotective effect of Coptis Chinensis in MPP and MPTP-induced Parkinson\u2019s disease models [J]. Am J Chin Med. 2016;44(5):907\u201325.","journal-title":"Am J Chin Med"},{"key":"2029_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopha.2016.03.038","volume":"81","author":"L Cui","year":"2016","unstructured":"Cui L, Liu M, Chang X, Sun K. The inhibiting effect of the Coptis Chinensis polysaccharide on the type II diabetic mice [J]. Biomed Pharmacother. 2016;81:111\u20139.","journal-title":"Biomed Pharmacother"},{"key":"2029_CR14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jep.2016.05.046","volume":"189","author":"E Kim","year":"2016","unstructured":"Kim E, Ahn S, Rhee HI, Lee DC. Coptis Chinensis Franch. Extract up-regulate type I helper T-cell cytokine through MAPK activation in MOLT-4 T cell [J]. J Ethnopharmacol. 2016;189:126\u201331.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2029_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5487\/TR.2014.30.1.045","volume":"30","author":"J Jung","year":"2014","unstructured":"Jung J, Choi JS, Jeong CS. Inhibitory activities of Palmatine from Coptis Chinensis against Helicobactor pylori and gastric damage [J]. Toxicol Res. 2014;30(1):45\u20138.","journal-title":"Toxicol Res"},{"issue":"9","key":"2029_CR16","first-page":"1185","volume":"35","author":"L Dong","year":"2010","unstructured":"Dong L, Shi H, Ji G, Wu D. Effects of Coptis Chinensis and Evodia rutaecarpa water extract on DMH-induced precancerous lesion of colon [J]. Zhongguo Zhong Yao Za Zhi. 2010;35(9):1185\u20138.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"5","key":"2029_CR17","doi-asserted-by":"crossref","first-page":"e0123478","DOI":"10.1371\/journal.pone.0123478","volume":"10","author":"X Liu","year":"2015","unstructured":"Liu X, Ji Q, Ye N, Sui H, Zhou L, Zhu H, Fan Z, Cai J, Li Q. Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2\/PGE2 mediated JAK2\/STAT3 signaling pathway [J]. PLoS One. 2015;10(5):e0123478.","journal-title":"PLoS One"},{"issue":"6","key":"2029_CR18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.phymed.2009.08.012","volume":"17","author":"JB Kim","year":"2010","unstructured":"Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancercell lines by inducing cell cycle arrest [J]. Phytomedicine. 2010;17(6):436\u201340.","journal-title":"Phytomedicine"},{"issue":"1","key":"2029_CR19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/or.2016.4785","volume":"36","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Jing Z, Li Y, Mao W. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis [J]. Oncol Rep. 2016;36(1):567\u201372.","journal-title":"Oncol Rep"},{"issue":"1","key":"2029_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","volume":"4","author":"GP Delcuve","year":"2012","unstructured":"Delcuve GP, Khan DH, Davie JR. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors [J]. Clin Epigenetics. 2012;4(1):5.","journal-title":"Clin Epigenetics"},{"issue":"2\u20133","key":"2029_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cytogfr.2010.03.002","volume":"21","author":"TL Nguyen","year":"2010","unstructured":"Nguyen TL, Wilson MG, Hiscott J. Oncolytic viruses and histone deacetylase inhibitors-a multi-pronged strategy to target tumor cells [J]. Cytokine Growth Factor Rev. 2010;21(2\u20133):153\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"2029_CR22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.exphem.2006.02.014","volume":"34","author":"C Leng","year":"2006","unstructured":"Leng C, Gries M, Ziegler J, Lokshin A, Mascagni P, Lentzsch S, Mapara MY. Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is asscociated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1 [J]. Exp Hematol. 2006;34(6):776\u201387.","journal-title":"Exp Hematol"},{"issue":"2","key":"2029_CR23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4149\/neo_2017_209","volume":"64","author":"I Burianova","year":"2017","unstructured":"Burianova I, Kuzelova K, Mitrovsky O, Spicka I, StOckbauer P, Zackova M. Histone deacetylase inhibitors in plasma cell leukemia treatment: effect of bone marrow microenvironment [J]. Neoplasma. 2017;64(2):228\u201337.","journal-title":"Neoplasma"},{"issue":"11","key":"2029_CR24","doi-asserted-by":"crossref","first-page":"e80657","DOI":"10.1371\/journal.pone.0080657","volume":"8","author":"D Feng","year":"2013","unstructured":"Feng D, Wu J, Tian Y, Zhou H, Zhou Y, Hu W, Zhao W, Wei H, Ling B, Ma C. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model [J]. PLoS One. 2013;8(11):e80657.","journal-title":"PLoS One"},{"issue":"3","key":"2029_CR25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/156652412799218949","volume":"12","author":"D Feng","year":"2012","unstructured":"Feng D, Cao Z, Li C, Zhang L, Zhou Y, Ma J, Liu R, Zhou H, Zhao W, Wei H, Ling B. Combination of valproic acid and ATRA restores RAR\u03b22 expression and induces differentiation in cervical cancer through the PI3K\/Akt pathway [J]. Curr Mol Med. 2012;12(3):342\u201354.","journal-title":"Curr Mol Med"},{"issue":"2","key":"2029_CR26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcp.10364","volume":"197","author":"V Calo","year":"2003","unstructured":"Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis [J]. J Cell Physiol. 2003;197(2):157\u201368.","journal-title":"J Cell Physiol"},{"issue":"2","key":"2029_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2006.10.017","volume":"251","author":"DA Frank","year":"2007","unstructured":"Frank DA. STAT3 as a central mediator of neoplastic cellular transformation [J]. Cancer Lett. 2007;251(2):199\u2013210.","journal-title":"Cancer Lett"},{"issue":"6","key":"2029_CR28","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/leu.2011.340","volume":"26","author":"M Gupta","year":"2012","unstructured":"Gupta M, Han JJ, Stenson M, Wellik L, Witzig TE. Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy [J]. Leukemia. 2012;26(6):1356\u201364.","journal-title":"Leukemia"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-017-2029-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T07:22:40Z","timestamp":1512544960000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-017-2029-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2029"],"URL":"https:\/\/doi.org\/10.1186\/s12906-017-2029-0","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"524"}}